United Kingdom

September 26, 2022

FUJIFILM Sonosite announces the European launch of Sonosite LX, the industry leader’s latest premium point-of-care ultrasound system

Combines the company’s largest clinical image yet with proprietary advanced image clarity designed to enable greater diagnostic and procedural confidence and improve collaboration

About Fujifilm 

FUJIFILM Sonosite, Inc. is the innovator and world leader in bedside and point-of-care ultrasound, and an industry leader in ultra-high frequency micro-ultrasound technology. Headquartered near Seattle, the company is represented by a global distribution network in over 100 countries. Sonosite’s portable, compact systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high-performance ultrasound to the point of patient care. For more information, please visit www.sonosite.com
 
FUJIFILM Holdings Corporation, Tokyo, leverages its depth of knowledge and proprietary core technologies to deliver Value from Innovation in our products and services in the business segments of healthcare, materials, business innovation, and imaging. Our relentless pursuit of innovation is focused on providing social value and enhancing the lives of people worldwide. Fujifilm is committed to responsible environmental stewardship and good corporate citizenship. For more information about Fujifilm’s Sustainable Value Plan 2030, click here.  
 
For the year ended March 31, 2022, the company had global revenues of approximately 2.5 trillion yen (21 billion $USD at an exchange rate of 122 yen/dollar). For more information, please visit: www.fujifilmholdings.com.  
 

Contact 

Todd Langton 
Corporate Communications Manager 
FUJIFILM Sonosite 
Todd.Langton@fujifilm.com
1.425.381.9290 (Cell)